euro adhoc: Bayer Schering Pharma AG / Half-yearly Report / Announcement according to articles 37v ff. WpHG [Securities Trading Act] with the aim of a Europe-wide distribution

--------------------------------------------------------------------------------
Tip announcement for financial statements transmitted by euro adhoc. The
issuer is responsible for the content of this announcement.
--------------------------------------------------------------------------------

The financial statement is available:
-------------------------------------
in the internet at: http://www.schering.de/scripts/en/40_ir/2008/fin_rep/080901_q2.php?n=irr2
in the internet on: 01.09.2008

end of announcement euro adhoc
--------------------------------------------------------------------------------

emitter: Bayer Schering Pharma AG
Müllerstrasse 178
D-13353 Berlin
phone: +49 (0)30 468 1111
FAX: +49 (0)30 468 15305
mail: ir@bayer-ag.de
WWW: www.schering.de
sector: Pharmaceuticals
ISIN: DE0007172009
indexes: CDAX
stockmarkets: regulated dealing: Börse Berlin, Börse Hamburg, Börse Stuttgart,
Börse Düsseldorf, Börse Hannover, Börse München, regulated
dealing/general standard: Börse Frankfurt
language: English

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | OTB

print